The Federal Reserve’s dual mandate—maximum employment and price stability—has always been a balancing act. But in 2025, the stakes are […]

In a bold move that rattled investors, Goldman Sachs downgraded Novartis (SIX:NOVN) from “Neutral” to “Sell” on September 12, 2025,

In July 2025, the U.S. Bureau of Labor Statistics (BLS) released a jobs report that sent shockwaves through political and

“Take off by the fourth quarter”: parsing Bessent’s prediction through current U.S. data Treasury Secretary Scott Bessent said the U.S.

Ionis Pharma (IONS) Hits Record High on Olezarsen Phase III Success Ionis Pharmaceuticals (NASDAQ: IONS) shares surged to an intraday

Nvidia Corporation has transformed from a niche graphics‐chip startup in 1993 into one of the most valuable technology companies in

Altria Group (NYSE: MO) has emerged as a standout dividend yield stock in 2025, delivering total returns of more than

📈 UnitedHealth’s Recent Surge: What’s Driving the Rally? UnitedHealth Group Inc. (NYSE: UNH) has stunned Wall Street with a dramatic

Palantir’s Ultra-Expensive Valuation Sparks Worry Ahead of Q2 Results Palantir Technologies (NASDAQ: PLTR) has become one of the most talked-about

JPMorgan’s Bearish Outlook on Circle Internet Group and Tesla: Key Risks & Catalysts In late July 2025, JPMorgan Chase analysts